HomeAGMB • NASDAQ
add
Agomab Therapeutics NV
Previous close
$10.70
Day range
$10.36 - $11.16
Year range
$9.00 - $17.45
Market cap
543.88M USD
Avg Volume
201.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.53M | 39.89% |
Net income | -17.40M | -48.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -16.47M | -39.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 116.51M | -32.05% |
Total assets | 153.71M | -25.51% |
Total liabilities | 22.80M | 24.77% |
Total equity | 130.90M | — |
Shares outstanding | 2.09M | — |
Price to book | 0.17 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.40M | -48.32% |
Cash from operations | -13.17M | -5.90% |
Cash from investing | -30.00M | -8,165.56% |
Cash from financing | -34.00K | -100.04% |
Net change in cash | -43.16M | -162.68% |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
62
